Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.